133 results
Page 4 of 7
8-K
EX-99.2
bxx6n6 zq71m
22 Jun 20
Invitae and ArcherDX to create a global leader in comprehensive cancer genetics and precision oncology
4:55pm
8-K
EX-99.3
6p3oi u0i01
22 Jun 20
Invitae and ArcherDX to create a global leader in comprehensive cancer genetics and precision oncology
4:55pm
8-K
EX-99.1
ttqn58 64eqtrn
22 Jun 20
Invitae and ArcherDX to create a global leader in comprehensive cancer genetics and precision oncology
4:55pm
8-K
EX-99.4
335tsk4o4m3z0
22 Jun 20
Invitae and ArcherDX to create a global leader in comprehensive cancer genetics and precision oncology
4:55pm
S-3ASR
EX-4.2
1lfb v6oyfinrnr
20 Apr 20
Automatic shelf registration
4:59pm
S-3ASR
EX-4.2
gwz bmauaj9ubyz
20 Apr 20
Automatic shelf registration
4:55pm
D
kt9a oggcky08hjwej8
13 Apr 20
$19.68M in equity, sold $19.68M, 5 investors
12:00am
D
f0i 92o06wfuh
13 Apr 20
$52.37M in equity, sold $52.37M, 58 investors
12:00am
S-3ASR
EX-4.2
y12u4ucrsjwl272c2eq1
18 Mar 20
Automatic shelf registration
10:00pm
S-3ASR
EX-4.2
dozimy
18 Nov 19
Automatic shelf registration
5:18pm
8-K
EX-4.1
7c62z7
11 Sep 19
Invitae Prices Upsized Offering of $300 Million of Convertible Senior Notes
4:07pm